ASP Isotopes has three undisclosed contracts: one with a major U.S. semiconductor company (likely Intel), one with a large global industrial-gases company (likely Linde), and one with a large U.S. buyer. The thesis is that Intel's silicon spin-qubit quantum computing program is a strong strategic fit for ASP's enriched silicon-28 production, particularly given Intel's Hitachi collaboration announced in July 2026.

Linde (LIN) is positioned to benefit from dual growth catalysts: rocket fuel demand (liquid oxygen/nitrogen for SpaceX and liquid hydrogen for NASA/international rockets) and emerging hydrogen-based data center power solutions for AI infrastructure. Key risks include execution delays at new facilities, competition from alternative energy solutions, and dependency on government/space industry capex cycles.